CClinicalTrials.gg
CompletedNCT04927273Updated Jun 15, 2021

Availability of Spine Neuronavigation in Africa

An observational study in Spine Disease, sponsored by Association of Future African Neurosurgeons, Yaounde, Cameroon. Completed at 1 site in Cameroon. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-15.

Sponsored by Association of Future African Neurosurgeons, Yaounde, Cameroon · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
113
Ages
18 Years and older
Sex
All
01

Study summary

In this study, the availability of spine neuronavigation in Africa was evaluated. Access to surgical equipment is an important goal of global surgery and global neurosurgery. The study findings show that there are regional differences in access to spine neuronavigation techniques and highlight that the major barriers to increased prevalence are cost and lack of trained personnel.

02

Conditions studied

  • Spine Disease

Browse trials for

Keywords

  • Access
  • Africa
  • computer-assisted surgery
  • neuronavigation
  • spine surgery
03

In context

Spinal Diseases

267 studies on the registry are indexed under Spinal Diseases; 54 are open to participants now.

This study's enrollment of 113 is close to the median of 108 across 87 observational studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

Association of Future African Neurosurgeons, Yaounde, Cameroon is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Neurological and orthopedic surgery residents, fellows and consultants working in Africa.

Inclusion criteria

  • Neurological and orthopedic surgery residents, fellows and consultants working in Africa.

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
113 participants (actual)
Target follow-up
1 Month
Patient registry
Yes

Interventions

  • OtherSurvey

    Surveyed neurological and orthopedic surgeons

06

What researchers measure

Primary outcomes

  1. Availability of neuronavigation

    Number of neuronavigation units as discrete unitless counts available at African neurosurgery centers will be collected using an electronic survey

    Time frame: 1 month

07

Study locations

1 site
  • Association of Future African Neurosurgeons
    Yaounde, Centre 6356, Cameroon
08

References and documents

Individual participant data

Plan to share: No — Deidentified data will be shared with authorized personnel only.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04927273
Lead sponsor
Association of Future African Neurosurgeons, Yaounde, Cameroon
Collaborators
Washington University School of Medicine
Responsible party
Sponsor
First posted
Jun 15, 2021
Start date
Jan 24, 2021
Primary completion
Feb 23, 2021
Completion
Mar 30, 2021
Last update
Jun 15, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion